Left ventricular assist device: Difference between revisions
Jump to navigation
Jump to search
imported>Meg Taylor m (moved Left Ventricular Assist Device to Left ventricular assist device: Correct name format) |
imported>Meg Taylor No edit summary |
||
| Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
A ''' | A '''left ventricular assist device''' or '''LVAD''' is a [[pump]] which runs in parallel with a [[heart]] to boost the blood flow. The main reason for a patient to have a LVAD implanted is for [[bridge to transplant]] (BTT) or [[destination therapy]] (DT). Currently, the top three companies in this field are: | ||
#[[Thoratec]] - Heartmate2 market capital $2B US | #[[Thoratec]] - Heartmate2 market capital $2B US | ||
#[[Ventracor]] - VentrAssist | #[[Ventracor]] - VentrAssist | ||
#[[Heartware]] | #[[Heartware]] | ||
Revision as of 18:27, 2 October 2013
A left ventricular assist device or LVAD is a pump which runs in parallel with a heart to boost the blood flow. The main reason for a patient to have a LVAD implanted is for bridge to transplant (BTT) or destination therapy (DT). Currently, the top three companies in this field are: